Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 272 entries
View as:

Study of Long-term Use of Forlax® in Elderly Patients With Chronic Constipation

Phase: N/A Priority: Normal
NCT ID: NCT00276354 Org: User:
Start: 12/31/99 End: 11/20/01 Due: 11/20/02

Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT02493946 Org: User:
Start: 04/30/15 End: 12/31/16 Due: 12/31/17

Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?

Phase: N/A Priority: Normal
NCT ID: NCT00455637 Org: User:
Start: 03/31/07 End: 03/17/08 Due: 03/17/09

Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression

Phase: N/A Priority: Normal
NCT ID: NCT02321436 Org: User:
Start: 12/31/14 End: 03/31/16 Due: 03/31/17

Study to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT03895463 Org: User:
Start: 08/31/19 End: 03/26/23 Due: 03/26/24

To Document the Effectiveness of BoNT-A Injection in Adult Subjects With Upper Limb Spasticity Following Stroke

Phase: N/A Priority: Normal
NCT ID: NCT01020500 Org: User:
Start: 01/31/10 End: 05/31/11 Due: 05/31/12

A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01732549 Org: User:
Start: 01/31/13 End: 05/31/15 Due: 05/31/16

Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England

Phase: N/A Priority: Normal
NCT ID: NCT04637204 Org: User:
Start: 11/24/20 End: 12/11/20 Due: 12/11/21

Efficacy and Tolerability of Lanreotide (Autogel 120 mg) in Patients With Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT00499993 Org: User:
Start: 01/31/01 End: 05/31/03 Due: 05/31/04

Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea

Phase: N/A Priority: Normal
NCT ID: NCT03045926 Org: User:
Start: 08/31/16 End: 05/09/17 Due: 05/09/18

Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq

Phase: N/A Priority: Normal
NCT ID: NCT00234533 Org: User:
Start: 06/30/04 End: 07/31/08 Due: 07/31/09

Predictive Factors Study

Phase: N/A Priority: Normal
NCT ID: NCT02020499 Org: User:
Start: 08/31/14 End: 09/30/15 Due: 09/30/16

Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT03894540 Org: User:
Start: 03/22/19 End: 12/21/20 Due: 12/21/21

Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01251354 Org: User:
Start: 11/30/10 End: 07/31/11 Due: 07/31/12

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1

Phase: N/A Priority: Normal
NCT ID: NCT02660138 Org: User:
Start: 03/31/16 End: 02/14/19 Due: 02/14/20

Efficacy, Safety and Tolerability of a New Bowel Cleansing Preparation (BLI800) in Adult Subjects Undergoing Colonoscopy

Phase: N/A Priority: Normal
NCT ID: NCT03562884 Org: User:
Start: 07/01/18 End: 04/28/19 Due: 04/28/20

Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00080015 Org: User:
Start: 03/12/04 End: 02/28/05 Due: 02/28/06

Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg

Phase: N/A Priority: Normal
NCT ID: NCT01257425 Org: User:
Start: 12/31/10 End: 05/31/12 Due: 05/31/13

Programme of Acromegaly Screening in Patients With Associated Somatic Disorders

Phase: N/A Priority: Normal
NCT ID: NCT02020967 Org: User:
Start: 12/05/13 End: 09/15/15 Due: 09/15/16

Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02683941 Org: User:
Start: 03/06/17 End: 02/28/20 Due: 02/28/21

Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03088813 Org: User:
Start: 04/25/18 End: 07/27/23 Due: 07/27/24

Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03419572 Org: User:
Start: 04/24/18 End: 05/19/22 Due: 05/19/23

68Ga-OPS202 Study for Diagnostic Imaging of GEP NET

Phase: N/A Priority: Normal
NCT ID: NCT02162446 Org: User:
Start: 06/30/14 End: 06/30/15 Due: 06/30/16

A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Extensor Digitorum Brevis Model in Healthy Adult Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT04970407 Org: User:
Start: 07/06/21 End: 06/08/22 Due: 06/08/23

GP Extended Action Triptorelin

Phase: N/A Priority: Normal
NCT ID: NCT01673984 Org: User:
Start: 08/31/12 End: 02/28/14 Due: 02/28/15